RSD-RS

Clinical Resources

Evidence-based information and treatment guidance for RSD in ADHD

Clinical Guidance Disclaimer

This information is provided for educational purposes to support clinical decision-making. It does not replace clinical judgement or individualised patient assessment. Off-label prescribing decisions should be made in accordance with local guidelines and regulations. All sources are cited for verification.

Medication Treatment for RSD
Frequently asked questions about pharmacological approaches to rejection sensitive dysphoria, based primarily on the clinical experience of Dr. William Dodson and current research.

Quick Reference: Alpha Agonist Dosing

Guanfacine (Intuniv)

  • Dose range: 0.5mg - 7mg daily
  • Titration: Start low, increase weekly
  • Response rate: ~30% as first-line

Clonidine (Kapvay)

  • Dose range: 0.1mg - 0.5mg daily
  • Titration: Start low, increase weekly
  • Note: Try if guanfacine ineffective

Source: ADDitude Magazine - Dr. William Dodson

Additional Reading
Peer-reviewed and authoritative sources on RSD and emotional dysregulation in ADHD

CHADD: Emotional Regulation in ADHD

Dr. Dodson's comprehensive article on emotional dysregulation and treatment approaches.

PDF

Cleveland Clinic: RSD Overview

Medical overview of RSD symptoms, causes, and treatment options.

Article

ADDitude: RSD and ADHD

Dr. Dodson's explanation of RSD, including medication protocols.

Article

Take Control ADHD Podcast: Dr. Dodson Interview

In-depth discussion of RSD treatment with Dr. William Dodson.

Podcast

Much of this information is based on the clinical experience and published work of Dr. William Dodson, MD, who has specialised in adult ADHD for over 30 years and first described the concept of Rejection Sensitive Dysphoria.